Literature DB >> 9291114

Regulation of the biosynthesis of 4,7,10,13,16-docosapentaenoic acid.

B S Mohammed1, D L Luthria, S P Bakousheva, H Sprecher.   

Abstract

It is now established that fatty acid 7,10,13,16-22:4 is metabolized into 4,7,10,13,16-22:5 as follows: 7,10,13,16-22:4-->9,12,15, 18-24:4-->6,9,12,15,18-24:5-->4,7,10,13,16-22:5. Neither C24 fatty acid was esterified to 1-acyl-sn-glycero-3-phosphocholine (1-acyl-GPC) by microsomes, whereas the rates of esterification of 4, 7,10,13,16-22:5, 7,10,13,16-22:4 and 5,8,11,14-20:4 were respectively 135, 18 and 160 nmol/min per mg of microsomal protein. About four times as much acid-soluble radioactivity was produced when peroxisomes were incubated with [3-14C]9,12,15,18-24:4 compared with 6,9,12,15,18-24:5. Only [1-14C]7,10,13,16-22:4 accumulated when [3-14C]9,12,15,18-24:4 was the substrate, but both 4,7,10,13,16-22:5 and 2-trans-4,7,10,13,16-22:6 were produced from [3-14C]6,9,12,15, 18-24:5. When the two C24 fatty acids were incubated with peroxisomes, microsomes and 1-acyl-GPC there was a decrease in the production of acid-soluble radioactivity from [3-14C]6,9,12,15, 18-24:5, but not from [3-14C]9,12,15,18-24:4. The preferential fate of [1-14C]4,7,10,13,16-22:5, when it was produced, was to move out of peroxisomes for esterification into the acceptor, whereas only small amounts of 7,10,13,16-22:4 were esterified. By using 2H-labelled 9,12,15,18-24:4 it was shown that, when 7,10,13,16-22:4 was produced, its primary metabolic fate was degradation to yield esterified arachidonate. Collectively, the results show that an inverse relationship exists between rates of peroxisomal beta-oxidation and of esterification into 1-acyl-GPC by microsomes. Most importantly, when a fatty acid is produced with its first double bond at position 4, it preferentially moves out of peroxisomes for esterification to 1-acyl-GPC by microsomes, rather than being degraded further via a cycle of beta-oxidation that requires NADPH-dependent 2,4-dienoyl-CoA reductase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291114      PMCID: PMC1218687          DOI: 10.1042/bj3260425

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.

Authors:  S A Moore; E Hurt; E Yoder; H Sprecher; A A Spector
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

2.  Biosynthesis of docosahexaenoic acid in human cells: evidence that two different delta 6-desaturase activities may exist.

Authors:  I Marzo; M A Alava; A Piñeiro; J Naval
Journal:  Biochim Biophys Acta       Date:  1996-06-11

3.  Peroxisomes contain delta 3,5,delta 2,4-dienoyl-CoA isomerase and thus possess all enzymes required for the beta-oxidation of unsaturated fatty acids by a novel reductase-dependent pathway.

Authors:  X Y He; K Shoukry; C Chu; J Yang; H Sprecher; H Schulz
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

4.  Purification and properties of long-chain acyl-CoA hydrolases from the liver cytosol of rats treated with peroxisome proliferator.

Authors:  J Yamada; I Matsumoto; T Furihata; M Sakuma; T Suga
Journal:  Arch Biochem Biophys       Date:  1994-01       Impact factor: 4.013

5.  Reevaluation of the pathway for the metabolism of 7,10,13, 16-docosatetraenoic acid to 4,7,10,13,16-docosapentaenoic acid in rat liver.

Authors:  B S Mohammed; S Sankarappa; M Geiger; H Sprecher
Journal:  Arch Biochem Biophys       Date:  1995-02-20       Impact factor: 4.013

6.  Arachidonic acid formed by peroxisomal beta-oxidation of 7,10,13,16-docosatetraenoic acid is esterified into 1-acyl-sn-glycero-3-phosphocholine by microsomes.

Authors:  S P Baykousheva; D L Luthria; H Sprecher
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

7.  Formation and release of a peroxisome-dependent arachidonic acid metabolite by human skin fibroblasts.

Authors:  J A Gordon; S K Heller; T L Kaduce; A A Spector
Journal:  J Biol Chem       Date:  1994-02-11       Impact factor: 5.157

8.  Metabolism of deuterium-labeled linoleic, 6,9,12-octadecatrienoic, 8,11,14-eicosatrienoic, and arachidonic acids in the rat.

Authors:  D L Luthria; H Sprecher
Journal:  J Lipid Res       Date:  1995-09       Impact factor: 5.922

9.  Peroxisome proliferators differentially regulate long-chain acyl-CoA thioesterases in rat liver.

Authors:  L T Svensson; M Wilcke; S E Alexson
Journal:  Eur J Biochem       Date:  1995-06-01

10.  Peroxisomal-microsomal communication in unsaturated fatty acid metabolism.

Authors:  S P Baykousheva; D L Luthria; H Sprecher
Journal:  FEBS Lett       Date:  1995-06-26       Impact factor: 4.124

View more
  3 in total

1.  The fatty acid desaturase 2 (FADS2) gene product catalyzes Δ4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells.

Authors:  Hui Gyu Park; Woo Jung Park; Kumar S D Kothapalli; J Thomas Brenna
Journal:  FASEB J       Date:  2015-06-11       Impact factor: 5.191

2.  Effect of the delta6-desaturase inhibitor SC-26196 on PUFA metabolism in human cells.

Authors:  Shawn D Harmon; Terry L Kaduce; Tony D Manuel; Arthur A Spector
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

Review 3.  Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process.

Authors:  H Sprecher; Q Chen; F Q Yin
Journal:  Lipids       Date:  1999       Impact factor: 1.646

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.